Alterome Therapeutics is a biopharmaceutical company with a mission to develop targeted cancer therapies, focusing on hard-to-treat cancer targets. The company utilizes a combination of advanced scientific disciplines, including chemistry, biology, pharmacology, and genomics aiming to create selective, small-molecule therapies aimed at transforming the lives of its patients. Alterome Therapeutics was founded by Eric A Murphy in 2021 and is headquartered in San Diego, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
04/03/2024 | Series B | $132MM | $xx.xx | $356.19MM | Goldman Sachs Alternatives, Canaan Partners, Invus, Driehaus Capital Management, Digitalis Ventures, Blue Owl Capital, Orbimed, Nextech Invest, Vida Ventures, Boxer Capital, Colt Ventures | |
Price per Share
$xx.xx
Shares Outstanding
32,314,919
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Goldman Sachs Alternatives, Canaan Partners, Invus, Driehaus Capital Management, Digitalis Ventures, Blue Owl Capital, Orbimed, Nextech Invest, Vida Ventures, Boxer Capital, Colt Ventures
|
||||||
11/02/2022 | Series A-2 | $35.27MM | $xx.xx | $186.39MM | Colt Ventures, OrbiMed, Nextech Invest, Vida Ventures, Boxer Capital | |
Price per Share
$xx.xx
Shares Outstanding
9,930,989
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Colt Ventures, OrbiMed, Nextech Invest, Vida Ventures, Boxer Capital
|
||||||
01/19/2022 | Series A | $63.8MM | $xx.xx | $127.6MM | OrbiMed, Nextech Invest, Vida Ventures, Boxer Capital | |
Price per Share
$xx.xx
Shares Outstanding
21,554,051
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
OrbiMed, Nextech Invest, Vida Ventures, Boxer Capital
|